Farmington, Connecticut 06030

  • Aplasia Cutis Congenita


The goal of this research study is to identify genes and regulatory elements on chromosomes that cause ACC. The investigators also study tissue samples from patients to learn about the processes that lead to this disorder.

Study summary:

Aplasia cutis congenita (ACC) or congenital scalp defect is a very rare disorder that affects bone and skin. The definition for ACC is the localized absence of (normal) skin at the time of birth (congenital). The skin appears thinner and the underlying structures are visible. We study mostly the isolated form of ACC with the lesion often being at the vertex of the skull (at or close to the top of the skull). The bone underlying the lesion is sometimes thinner as well. For this study we will: - Send out study participation kits and consent by phone - Collect a saliva sample from eligible individuals - Obtain information regarding ACC - Document disorder with photos and doctor's letters - If patients undergo surgery for ACC we ask to obtain some tissue that would otherwise be discarded - Isolate DNA from the saliva sample - Perform genetic analyses of the DNA with the most up-to-date methods available to identify genetic variations - Study in the laboratory why the genetic variations cause the disorder


Inclusion Criteria: - ACC; unaffected individuals only if part of a participating ACC family Exclusion Criteria: - No ACC unaffected individuals only as part of a participating ACC family



Primary Contact:

Principal Investigator
Ernst J Reichenberger, PhD
UConn Health

Ernst J Reichenberger, PhD
Phone: 860-679-2062

Backup Contact:


Location Contact:

Farmington, Connecticut 06030
United States

Ernst J Reichenberger, PhD
Phone: 860-679-2062

Site Status: Recruiting

Data Source:

Date Processed: September 27, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.